In the last 12 months, insiders at Traws Pharma, Inc. ($TRAW) filed 130 transactions with the SEC: 12 open-market purchases totaling $998,207 and 0 sales totaling $0. Net insider sentiment: net buying.
Traws Pharma, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- ORBIMED ADVISORS LLC (TenPercentOwner) — 6 transactions totaling $998,207
- Fruchtman Steven M (PRESIDENT, CHIEF EXECUTIVE OFF) — 14 transactions totaling $28,307
- Guerin Mark Patrick (CFO AND COO) — 17 transactions totaling $9,638
- Gelder Mark S. MD (CHIEF MEDICAL OFFICER) — 5 transactions totaling $1,689
- Guerin Mark Patrick (CFO) — 3 transactions totaling $1,044
View all SEC Filings for Traws Pharma, Inc. (TRAW).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 16, 2026 | ORBIMED ADVISORS LLC | TenPercentOwner | P | Series C Warrants (right to buy) | 1793187 | $0.00 | 1,793,187.0000 | 8,376,380 | 9999.99% | 21.41% |
| April 16, 2026 | ORBIMED ADVISORS LLC | TenPercentOwner | P | Common Stock | 597729 | $1.67 | 1,203,250.0000 | 8,376,380 | 98.71% | 7.14% |
| April 16, 2026 | ORBIMED ADVISORS LLC | TenPercentOwner | P | Series A Warrants (right to buy) | 597729 | $0.00 | 597,729.0000 | 8,376,380 | 9999.99% | 7.14% |
| April 16, 2026 | ORBIMED ADVISORS LLC | TenPercentOwner | P | Series B Warrants (right to buy) | 597729 | $0.00 | 597,729.0000 | 8,376,380 | 9999.99% | 7.14% |
| March 8, 2026 | Parker Charles Nolan | Chief Financial Officer | A | Stock Option (right to buy) | 104544 | $0.00 | 104,544.0000 | 8,818,859 | 9999.99% | 1.19% |
| Dec. 12, 2025 | Parker Charles Nolan | Chief Financial Officer | A | Common Stock | 15393 | $0.00 | 15,393.0000 | 8,818,859 | 9999.99% | 0.17% |
| Oct. 12, 2025 | Parker Charles Nolan | Chief Financial Officer | A | Stock Option (right to buy) | 32406 | $0.00 | 32,406.0000 | 8,818,859 | 9999.99% | 0.37% |
| Dec. 12, 2025 | Parker Charles Nolan | Chief Financial Officer | A | Stock Option (right to buy) | 61571 | $0.00 | 61,571.0000 | 8,818,859 | 9999.99% | 0.70% |
| March 8, 2026 | Redfield Robert | Chief Medical Officer | A | Stock Option (right to buy) | 108854 | $0.00 | 108,854.0000 | 8,818,859 | 9999.99% | 1.23% |
| March 8, 2026 | Shoemaker Mary Teresa | Not found | A | Stock Option (right to buy) | 33435 | $0.00 | 33,435.0000 | 8,818,859 | 9999.99% | 0.38% |
| March 8, 2026 | Clarke Trafford | Not found | A | Stock Option (right to buy) | 33435 | $0.00 | 33,435.0000 | 8,818,859 | 9999.99% | 0.38% |
| March 8, 2026 | CAUTREELS WERNER | Not found | A | Stock Option (right to buy) | 31258 | $0.00 | 31,258.0000 | 8,818,859 | 9999.99% | 0.35% |
| March 8, 2026 | Dukes Iain D. | Chief Executive Officer | A | Stock Option (right to buy) | 231336 | $0.00 | 231,336.0000 | 8,818,859 | 9999.99% | 2.62% |
| March 8, 2026 | Leaman John Harold | Not found | A | Stock Option (right to buy) | 33435 | $0.00 | 33,435.0000 | 8,818,859 | 9999.99% | 0.38% |
| March 8, 2026 | Pauza Charles David | Chief Science Officer Virology | A | Stock Option (right to buy) | 118367 | $0.00 | 118,367.0000 | 8,818,859 | 9999.99% | 1.34% |
| March 8, 2026 | Savchuk Nikolay | Chief Operating Officer | A | Stock Option (right to buy) | 96899 | $0.00 | 96,899.0000 | 8,818,859 | 9999.99% | 1.10% |
| March 8, 2026 | STOVER JACK E | Not found | A | Stock Option (right to buy) | 33435 | $0.00 | 33,435.0000 | 8,818,859 | 9999.99% | 0.38% |
| Dec. 12, 2025 | Clarke Trafford | Not found | A | Stock Option (right to purchase) | 24629 | $0.00 | 24,629.0000 | 8,818,859 | 9999.99% | 0.28% |
| Dec. 12, 2025 | Savchuk Nikolay | Chief Operating Officer | A | Stock Option (right to purchase) | 65676 | $0.00 | 65,676.0000 | 8,818,859 | 9999.99% | 0.74% |
| Dec. 12, 2025 | Savchuk Nikolay | Chief Operating Officer | A | Common Stock | 16419 | $0.00 | 150,606.0000 | 8,818,859 | 12.24% | 0.19% |
| Dec. 12, 2025 | Redfield Robert | Chief Medical Officer | A | Stock Option (right to purchase) | 65676 | $0.00 | 65,676.0000 | 8,818,859 | 9999.99% | 0.74% |
| Dec. 12, 2025 | Redfield Robert | Chief Medical Officer | A | Common Stock | 16419 | $0.00 | 113,919.0000 | 8,818,859 | 16.84% | 0.19% |
| Dec. 12, 2025 | Pauza Charles David | Chief Science Officer Virology | A | Stock Option (right to purchase) | 73886 | $0.00 | 73,886.0000 | 8,818,859 | 9999.99% | 0.84% |
| Dec. 12, 2025 | Pauza Charles David | Chief Science Officer Virology | A | Common Stock | 18471 | $0.00 | 115,971.0000 | 8,818,859 | 18.94% | 0.21% |
| Dec. 12, 2025 | Dukes Iain D. | Chief Executive Officer | A | Stock Option (right to purchase) | 147771 | $0.00 | 147,771.0000 | 8,818,859 | 9999.99% | 1.68% |
| Dec. 12, 2025 | Dukes Iain D. | Chief Executive Officer | A | Common Stock | 36943 | $0.00 | 171,130.0000 | 8,818,859 | 27.53% | 0.42% |
| Dec. 12, 2025 | STOVER JACK E | Not found | A | Stock Option (right to purchase) | 24629 | $0.00 | 24,629.0000 | 8,818,859 | 9999.99% | 0.28% |
| Dec. 12, 2025 | STOVER JACK E | Not found | A | Common Stock | 6157 | $0.00 | 6,165.0000 | 8,818,859 | 9999.99% | 0.07% |
| Dec. 12, 2025 | Shoemaker Mary Teresa | Not found | A | Stock Option (right to purchase) | 24629 | $0.00 | 24,629.0000 | 8,818,859 | 9999.99% | 0.28% |
| Dec. 12, 2025 | Shoemaker Mary Teresa | Not found | A | Common Stock | 6157 | $0.00 | 6,292.0000 | 8,818,859 | 4560.74% | 0.07% |
| Dec. 12, 2025 | CAUTREELS WERNER | Not found | A | Stock Option (right to purchase) | 19496 | $0.00 | 19,496.0000 | 8,818,859 | 9999.99% | 0.22% |
| Dec. 12, 2025 | CAUTREELS WERNER | Not found | A | Common Stock | 4874 | $0.00 | 109,222.0000 | 8,818,859 | 4.67% | 0.06% |
| Dec. 12, 2025 | Leaman John Harold | Not found | A | Stock Option (right to purchase) | 16234 | $0.00 | 16,234.0000 | 8,818,859 | 9999.99% | 0.18% |
| Dec. 12, 2025 | Leaman John Harold | Not found | A | Common Stock | 4058 | $0.00 | 4,058.0000 | 8,818,859 | 9999.99% | 0.05% |
| Dec. 12, 2025 | Clarke Trafford | Not found | A | Common Stock | 6157 | $0.00 | 6,157.0000 | 8,818,859 | 9999.99% | 0.07% |
| Nov. 21, 2025 | Leaman John Harold | Not found | A | Stock Option (right to purchase) | 12770 | $0.00 | 12,770.0000 | 8,818,859 | 9999.99% | 0.14% |
| Oct. 12, 2025 | Clarke Trafford | Not found | A | Stock Option (right to purchase) | 11530 | $0.00 | 11,530.0000 | 8,818,859 | 9999.99% | 0.13% |
| Oct. 12, 2025 | Shoemaker Mary Teresa | Not found | A | Stock Option (right to purchase) | 11530 | $0.00 | 11,530.0000 | 8,818,859 | 9999.99% | 0.13% |
| Oct. 12, 2025 | STOVER JACK E | Not found | A | Stock Option (right to purchase) | 11530 | $0.00 | 11,530.0000 | 8,818,859 | 9999.99% | 0.13% |
| Oct. 12, 2025 | Savchuk Nikolay | Chief Operating Officer | A | Stock Option (right to purchase) | 22435 | $0.00 | 22,435.0000 | 8,818,859 | 9999.99% | 0.25% |
| Oct. 12, 2025 | Redfield Robert | Chief Medical Officer | A | Stock Option (right to purchase) | 32406 | $0.00 | 32,406.0000 | 8,818,859 | 9999.99% | 0.37% |
| Oct. 12, 2025 | Pauza Charles David | Chief Science Officer Virology | A | Stock Option (right to purchase) | 32406 | $0.00 | 32,406.0000 | 8,818,859 | 9999.99% | 0.37% |
| Oct. 12, 2025 | Dukes Iain D. | Chief Executive Officer | A | Stock Option (right to purchase) | 64839 | $0.00 | 64,839.0000 | 8,818,859 | 9999.99% | 0.74% |
| Oct. 12, 2025 | CAUTREELS WERNER | Not found | A | Stock Option (right to purchase) | 11530 | $0.00 | 11,530.0000 | 8,818,859 | 9999.99% | 0.13% |
| Oct. 1, 2025 | Leaman John Harold | Not found | A | Stock Option (right to purchase) | 15609 | $0.00 | 15,609.0000 | 8,818,859 | 9999.99% | 0.18% |
| June 19, 2025 | Clarke Trafford | Not found | A | Stock Option (right to purchase) | 23000 | $0.00 | 23,000.0000 | 7,215,125 | 9999.99% | 0.32% |
| June 19, 2025 | CAUTREELS WERNER | Not found | A | Stock Option (right to purchase) | 23000 | $0.00 | 23,000.0000 | 7,215,125 | 9999.99% | 0.32% |
| June 19, 2025 | Shoemaker Mary Teresa | Not found | A | Stock Option (right to purchase) | 23000 | $0.00 | 23,000.0000 | 7,215,125 | 9999.99% | 0.32% |
| June 19, 2025 | STOVER JACK E | Not found | A | Stock Option (right to purchase) | 23000 | $0.00 | 23,000.0000 | 7,215,125 | 9999.99% | 0.32% |
| April 2, 2025 | TPAV, LLC | TenPercentOwner | J | Common Stock | 605531 | $0.00 | 0.0000 | 7,215,125 | 100.00% | 8.39% |
| April 2, 2025 | TPAV, LLC | TenPercentOwner | J | Series C Preferred Stock | 2264 | $0.00 | 0.0000 | 7,215,125 | 100.00% | 0.03% |
| Feb. 18, 2025 | CAUTREELS WERNER | Chief Executive Officer | M | Common Stock | 96348 | $0.01 | 104,348.0000 | 1,552,685 | 1204.35% | 6.21% |
| Feb. 18, 2025 | CAUTREELS WERNER | Chief Executive Officer | M | Pre-Funded Warrant (right to buy) | 96348 | $0.00 | 0.0000 | 1,552,685 | 100.00% | 6.21% |
| Dec. 29, 2024 | Savchuk Nikolay | Chief Operating Officer | P | Series A Warrant (right to buy) | 96348 | $0.00 | 96,348.0000 | 961,530 | 9999.99% | 10.02% |
| Dec. 29, 2024 | Savchuk Nikolay | Chief Operating Officer | P | Pre-Funded Warrant (right to buy) | 96348 | $0.00 | 96,348.0000 | 961,530 | 9999.99% | 10.02% |
| Dec. 29, 2024 | TPAV, LLC | TenPercentOwner | P | Series A Warrant (right to buy) | 96348 | $0.00 | 96,348.0000 | 961,530 | 9999.99% | 10.02% |
| Dec. 29, 2024 | CAUTREELS WERNER | Chief Executive Officer | P | Series A Warrant (right to buy) | 96348 | $0.00 | 96,348.0000 | 961,530 | 9999.99% | 10.02% |
| Dec. 29, 2024 | TPAV, LLC | TenPercentOwner | P | Pre-Funded Warrant (right to buy) | 96348 | $0.00 | 96,348.0000 | 961,530 | 9999.99% | 10.02% |
| Dec. 29, 2024 | CAUTREELS WERNER | Chief Executive Officer | P | Pre-Funded Warrant (right to buy) | 96348 | $0.00 | 96,348.0000 | 961,530 | 9999.99% | 10.02% |
| Dec. 29, 2024 | ORBIMED ADVISORS LLC | TenPercentOwner | P | Series A Warrant (right to buy) | 96348 | $0.00 | 96,348.0000 | 961,530 | 9999.99% | 10.02% |
| Dec. 29, 2024 | ORBIMED ADVISORS LLC | TenPercentOwner | P | Pre-Funded Warrant (right to buy) | 96348 | $0.00 | 96,348.0000 | 961,530 | 9999.99% | 10.02% |
| Sept. 16, 2024 | Greenwood Luba | Not found | A | Stock Option (Right to Purchase) | 164000 | $0.00 | 164,000.0000 | 1,012,430 | 9999.99% | 16.20% |
| April 1, 2024 | Savchuk Nikolay | Chief Operating Officer | A | Common Stock | 67500 | $0.00 | 134,187.0000 | 841,738 | 101.22% | 8.02% |
| April 1, 2024 | Dukes Iain D. | Executive Chairman | A | Common Stock | 67500 | $0.00 | 134,187.0000 | 841,738 | 101.22% | 8.02% |
| June 18, 2024 | Guerin Mark Patrick | CFO | F | Common Stock | 2221 | $0.47 | 39,255.0000 | 841,738 | 5.35% | 0.26% |
| June 18, 2024 | Guerin Mark Patrick | CFO | M | Restricted Stock Units | 5500 | $0.00 | 5,500.0000 | 841,738 | 50.00% | 0.65% |
| June 10, 2024 | Guerin Mark Patrick | CFO | M | Common Stock | 5500 | $0.00 | 41,476.0000 | 841,738 | 15.29% | 0.65% |
| April 1, 2024 | Pauza Charles David | Chief Science Officer Virology | A | Common Stock | 97500 | $0.00 | 97,500.0000 | 841,738 | 9999.99% | 11.58% |
| April 1, 2024 | Pauza Charles David | Chief Science Officer Virology | A | Stock Option (right to purchase) | 333136 | $0.00 | 333,136.0000 | 841,738 | 9999.99% | 39.58% |
| April 1, 2024 | Pauza Charles David | Chief Science Officer Virology | A | Stock Option (right to purchase) | 503227 | $0.00 | 503,227.0000 | 841,738 | 9999.99% | 59.78% |
| April 1, 2024 | CAUTREELS WERNER | Chief Executive Officer | A | Common Stock | 200000 | $0.00 | 200,000.0000 | 841,738 | 9999.99% | 23.76% |
| April 1, 2024 | Dukes Iain D. | Executive Chairman | A | Series C Preferred Stock | 4801 | $0.00 | 4,995.7367 | 841,738 | 2466.89% | 0.57% |
| April 1, 2024 | Dukes Iain D. | Executive Chairman | A | Series C Preferred Stock | 195 | $0.00 | 4,995.7367 | 841,738 | 4.05% | 0.02% |
| April 1, 2024 | Dukes Iain D. | Executive Chairman | A | Stock Option (right to purchase) | 3802890 | $0.00 | 3,802,890.0000 | 841,738 | 9999.99% | 100.00% |
| April 1, 2024 | Dukes Iain D. | Executive Chairman | A | Common Stock | 1645100 | $0.00 | 1,779,287.0000 | 841,738 | 1225.98% | 100.00% |
| April 1, 2024 | Dukes Iain D. | Executive Chairman | A | Common Stock | 67550 | $0.00 | 1,779,287.0000 | 841,738 | 3.95% | 8.03% |
| April 1, 2024 | Dukes Iain D. | Executive Chairman | A | Common Stock | 66687 | $0.00 | 1,711,787.0000 | 841,738 | 4.05% | 7.92% |
| April 1, 2024 | Savchuk Nikolay | Chief Operating Officer | A | Series C Preferred Stock | 4801 | $0.00 | 7,580.1030 | 841,738 | 172.76% | 0.57% |
| April 1, 2024 | Savchuk Nikolay | Chief Operating Officer | A | Series C Preferred Stock | 2584 | $0.00 | 7,580.1030 | 841,738 | 51.73% | 0.31% |
| April 1, 2024 | Savchuk Nikolay | Chief Operating Officer | A | Series C Preferred Stock | 195 | $0.00 | 7,580.1030 | 841,738 | 2.64% | 0.02% |
| April 1, 2024 | Savchuk Nikolay | Chief Operating Officer | A | Stock Option (right to purchase) | 3802890 | $0.00 | 3,802,890.0000 | 841,738 | 9999.99% | 100.00% |
| April 1, 2024 | Savchuk Nikolay | Chief Operating Officer | A | Common Stock | 1645100 | $0.00 | 2,664,819.0000 | 841,738 | 161.33% | 100.00% |
| April 1, 2024 | Savchuk Nikolay | Chief Operating Officer | A | Common Stock | 885532 | $0.00 | 2,664,819.0000 | 841,738 | 49.77% | 100.00% |
| April 1, 2024 | Savchuk Nikolay | Chief Operating Officer | A | Common Stock | 67550 | $0.00 | 2,664,819.0000 | 841,738 | 2.60% | 8.03% |
| April 1, 2024 | Savchuk Nikolay | Chief Operating Officer | A | Common Stock | 66687 | $0.00 | 2,597,319.0000 | 841,738 | 2.64% | 7.92% |
| April 1, 2024 | Redfield Robert | Acting Chief Medical Officer | A | Common Stock | 97500 | $0.00 | 97,500.0000 | 841,738 | 9999.99% | 11.58% |
| March 14, 2024 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | F | Common Stock | 8727 | $0.90 | 74,792.0000 | 839,554 | 10.45% | 1.04% |
| March 13, 2024 | Guerin Mark Patrick | CFO AND COO | M | Common Stock | 8666 | $0.00 | 38,567.0000 | 839,554 | 28.98% | 1.03% |
| March 14, 2024 | Guerin Mark Patrick | CFO AND COO | F | Common Stock | 2591 | $0.90 | 35,976.0000 | 839,554 | 6.72% | 0.31% |
| March 13, 2024 | Guerin Mark Patrick | CFO AND COO | M | Restricted Stock Units | 8666 | $0.00 | 17,334.0000 | 839,554 | 33.33% | 1.03% |
| March 13, 2024 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | M | Common Stock | 23111 | $0.00 | 83,519.0000 | 839,554 | 38.26% | 2.75% |
| March 13, 2024 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | M | Restricted Stock Units | 23111 | $0.00 | 46,222.0000 | 839,554 | 33.33% | 2.75% |
| Feb. 7, 2024 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | M | Common Stock | 21320 | $0.00 | 69,620.0000 | 839,554 | 44.14% | 2.54% |
| Feb. 7, 2024 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | M | Restricted Stock Units | 21320 | $0.00 | 21,320.0000 | 839,554 | 50.00% | 2.54% |
| Feb. 7, 2024 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | F | Common Stock | 9212 | $0.67 | 60,408.0000 | 839,554 | 13.23% | 1.10% |
| Feb. 7, 2024 | Guerin Mark Patrick | CFO AND COO | M | Restricted Stock Units | 6900 | $0.00 | 6,900.0000 | 839,554 | 50.00% | 0.82% |
| Feb. 7, 2024 | Guerin Mark Patrick | CFO AND COO | F | Common Stock | 2443 | $0.67 | 29,901.0000 | 839,554 | 7.55% | 0.29% |
| Feb. 7, 2024 | Guerin Mark Patrick | CFO AND COO | M | Common Stock | 6900 | $0.00 | 32,344.0000 | 839,554 | 27.12% | 0.82% |
| Oct. 2, 2023 | Moyo Victor M | CHIEF MEDICAL OFFICER | A | Stock Option (right to purchase) | 125000 | $0.00 | 125,000.0000 | 840,117 | 9999.99% | 14.88% |
| Aug. 10, 2023 | Shoemaker Mary Teresa | Not found | A | Stock Option (right to purchase) | 66468 | $0.00 | 66,468.0000 | 20,979,766 | 9999.99% | 0.32% |
| Aug. 10, 2023 | STOVER JACK E | Not found | A | Stock Option (right to purchase) | 66468 | $0.00 | 66,468.0000 | 20,979,766 | 9999.99% | 0.32% |
| Aug. 10, 2023 | Atadja Peter | Not found | A | Stock Option (right to purchase) | 66468 | $0.00 | 66,468.0000 | 20,979,766 | 9999.99% | 0.32% |
| Aug. 10, 2023 | Clarke Trafford | Not found | A | Stock Option (right to purchase) | 66468 | $0.00 | 66,468.0000 | 20,979,766 | 9999.99% | 0.32% |
| Aug. 10, 2023 | MEHTA VIREN | Not found | A | Stock Option (right to purchase) | 66468 | $0.00 | 66,468.0000 | 20,979,766 | 9999.99% | 0.32% |
| Aug. 10, 2023 | MARINO JAMES J | Not found | A | Stock Option (right to purchase) | 66468 | $0.00 | 66,468.0000 | 20,979,766 | 9999.99% | 0.32% |
| Aug. 10, 2023 | GROOPMAN JEROME | Not found | A | Stock Option (right to purchase) | 66468 | $0.00 | 66,468.0000 | 20,979,766 | 9999.99% | 0.32% |
| Aug. 3, 2023 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | F | Common Stock | 4744 | $1.01 | 48,300.0000 | 20,979,766 | 8.94% | 0.02% |
| Aug. 2, 2023 | Guerin Mark Patrick | CFO AND COO | M | Common Stock | 4750 | $0.00 | 26,866.0000 | 20,979,766 | 21.48% | 0.02% |
| Aug. 3, 2023 | Guerin Mark Patrick | CFO AND COO | F | Common Stock | 1422 | $1.02 | 25,444.0000 | 20,979,766 | 5.29% | 0.01% |
| Aug. 2, 2023 | Guerin Mark Patrick | CFO AND COO | M | Restricted Stock Units | 4750 | $0.00 | 4,750.0000 | 20,979,766 | 50.00% | 0.02% |
| Aug. 2, 2023 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | M | Common Stock | 12567 | $0.00 | 53,044.0000 | 20,979,766 | 31.05% | 0.06% |
| Aug. 2, 2023 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | M | Restricted Stock Units | 12567 | $0.00 | 12,567.0000 | 20,979,766 | 50.00% | 0.06% |
| June 12, 2023 | Guerin Mark Patrick | CFO AND COO | F | Common Stock | 1575 | $1.14 | 22,116.0000 | 20,960,171 | 6.65% | 0.01% |
| June 12, 2023 | Guerin Mark Patrick | CFO AND COO | M | Common Stock | 5500 | $0.00 | 23,691.0000 | 20,960,171 | 30.23% | 0.03% |
| June 12, 2023 | Guerin Mark Patrick | CFO AND COO | M | Restricted Stock Units | 5500 | $0.00 | 11,000.0000 | 20,960,171 | 33.33% | 0.03% |
| March 13, 2023 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | A | Stock Option (right to purchase) | 207000 | $0.00 | 207,000.0000 | 20,908,235 | 9999.99% | 0.99% |
| March 13, 2023 | Gelder Mark S. MD | CHIEF MEDICAL OFFICER | A | Restricted Stock Units | 20667 | $0.00 | 20,667.0000 | 20,908,235 | 9999.99% | 0.10% |
| March 13, 2023 | Guerin Mark Patrick | CFO AND COO | A | Restricted Stock Units | 26000 | $0.00 | 26,000.0000 | 20,908,235 | 9999.99% | 0.12% |
| March 13, 2023 | Guerin Mark Patrick | CFO AND COO | A | Stock Option (right to purchase) | 79000 | $0.00 | 79,000.0000 | 20,908,235 | 9999.99% | 0.38% |
| March 13, 2023 | Gelder Mark S. MD | CHIEF MEDICAL OFFICER | A | Stock Option (right to purchase) | 62000 | $0.00 | 62,000.0000 | 20,908,235 | 9999.99% | 0.30% |
| March 13, 2023 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | A | Restricted Stock Units | 69333 | $0.00 | 69,333.0000 | 20,908,235 | 9999.99% | 0.33% |
| Feb. 7, 2023 | Guerin Mark Patrick | CFO AND COO | F | Common Stock | 1785 | $1.36 | 18,191.0000 | 20,908,235 | 8.94% | 0.01% |
| Feb. 7, 2023 | Guerin Mark Patrick | CFO AND COO | M | Restricted Stock Units | 6900 | $0.00 | 13,800.0000 | 20,908,235 | 33.33% | 0.03% |
| Feb. 7, 2023 | Gelder Mark S. MD | CHIEF MEDICAL OFFICER | M | Restricted Stock Units | 5833 | $0.00 | 11,667.0000 | 20,908,235 | 33.33% | 0.03% |
| Feb. 7, 2023 | Guerin Mark Patrick | CFO AND COO | M | Common Stock | 6900 | $0.00 | 19,976.0000 | 20,908,235 | 52.77% | 0.03% |
| Feb. 7, 2023 | Gelder Mark S. MD | CHIEF MEDICAL OFFICER | F | Common Stock | 1242 | $1.36 | 10,487.0000 | 20,908,235 | 10.59% | 0.01% |
| Feb. 7, 2023 | Gelder Mark S. MD | CHIEF MEDICAL OFFICER | M | Common Stock | 5833 | $0.00 | 11,729.0000 | 20,908,235 | 98.93% | 0.03% |
| Feb. 7, 2023 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | M | Restricted Stock Units | 21320 | $0.00 | 42,640.0000 | 20,908,235 | 33.33% | 0.10% |
| Feb. 7, 2023 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | F | Common Stock | 6977 | $1.36 | 40,477.0000 | 20,908,235 | 14.70% | 0.03% |
| Feb. 7, 2023 | Fruchtman Steven M | PRESIDENT, CHIEF EXECUTIVE OFF | M | Common Stock | 21320 | $0.00 | 47,454.0000 | 20,908,235 | 81.58% | 0.10% |